Back to publication

The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome

Assessed by RV003 · Research Fellow

Assessed on 30 Oct 2025

OverallReviewer's overall integrity assessment, derived from all research questions Serious concerns

DOI 10.1016/j.jad.2017.12.049 (opens in new tab)

Resource ripekg:research-integrity-assessment/RIPEA0C83AF9CE6274D42

5 Research Questions · 74 Evidence Items

Q1.1 — Does the study have an associated retraction?

Automated Assessment:Assessment produced by the automated systemNo
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsN/A

Rationale: No rationale provided

Q1.2 — Does the study have an associated expression of concern or other relevant post-publication notice?

Automated Assessment:Assessment produced by the automated systemYes
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsYes

Rationale: Integrity of research group questioned

Supporting Evidence (1)

PubPeer ThreadSource: PubPeer.com — post-publication peer review comments

https://pubpeer.com/publications/C62B49583B9C8562841A1222791F65 (opens in new tab)

PubPeer CommentSource: PubPeer.com — a platform for post-publication peer review

Commenter: Andrew GreyDate: 1 May 2021

There are many concerns about the integrity of 172 publications by this research group, including this one. Some of the concerns are published 1. Anaesthesia 2020;75:1683–92, see Supplementary data. This paper is A140 2. Account Res 2020;28:149-61. 3. J Clin Epidemiol 2021;131:22-29. Journals and publishers were notified of these concerns in July 2019. 18 publications have an expression of concern, and 6 have been retracted. To our knowledge there has been no public response about any of the concerns. We think these publications are unreliable

Thread: https://pubpeer.com/publications/C62B49583B9C8562841A1222791F65 (opens in new tab)

Q1.3 — Do other studies by the research team highlight causes for concern?

Automated Assessment:Assessment produced by the automated systemYes
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsYes

Rationale: A number of mentions for 9 authors

Supporting Evidence (71)

Retraction NoticeSource: Retraction Watch database

The Effect of Zinc Supplementation on Expressed Levels of Peroxisome Proliferator-Activated Receptor Gamma and Glucose Transporter Type 1 Genes in Newborns of Women with Gestational Diabetes Mellitus

10.1007/s12011-016-0788-y (opens in new tab)
Journal: Biological Trace Element ResearchPublisher: SpringerDate: 28 Feb 2021

RetractionWatch ID:Record identifier in the Retraction Watch database 28454

Rationale: Concerns/Issues About Data;Investigation by Company/Institution;Updated to Retraction

About Authors: Mehri Jamilian, Mansooreh Samimi, Esmat Aghadavod

Retraction NoticeSource: Retraction Watch database

Effects of Selenium Supplementation on Gene Expression Levels of Inflammatory Cytokines and Vascular Endothelial Growth Factor in Patients with Gestational Diabetes

10.1007/s12011-017-1045-8 (opens in new tab)
Journal: Biological Trace Element ResearchPublisher: SpringerDate: 28 Feb 2021

RetractionWatch ID:Record identifier in the Retraction Watch database 28465

Rationale: Concerns/Issues About Data;Investigation by Company/Institution

About Authors: Mehri Jamilian, Mansooreh Samimi, Esmat Aghadavod, Faraneh Afshar Ebrahimi

Retraction NoticeSource: Retraction Watch database

The Effect of Zinc Supplementation on Expressed Levels of Peroxisome Proliferator-Activated Receptor Gamma and Glucose Transporter Type 1 Genes in Newborns of Women with Gestational Diabetes Mellitus

10.1007/s12011-022-03501-2 (opens in new tab)
Journal: Biological Trace Element ResearchPublisher: SpringerDate: 24 Nov 2022

RetractionWatch ID:Record identifier in the Retraction Watch database 40895

Rationale: Concerns/Issues About Data;Concerns/Issues About Image;Concerns/Issues about Referencing/Attributions;Duplication of/in Article;Investigation by Company/Institution;Unreliable Results and/or Conclusions;Upgrade/Update of Prior Notice(s)

About Authors: Mehri Jamilian, Mansooreh Samimi, Esmat Aghadavod

Q2.2 — Are there concerns relating to the timing or absence of study registration?

Automated Assessment:Assessment produced by the automated systemYes
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsYes

Rationale: Study was registered after recruitment started

Supporting Evidence (2)

Clinical Trial RegistrationSource: Clinical trial registry (e.g. ClinicalTrials.gov, ISRCTN)

Registration ID: IRCT201605215623N79

Registry: IRCT

Registry Link: https://trialsearch.who.int/Trial2.aspx?TrialID=IRCT201605215623N79 (opens in new tab)

Registration Date: 25 May 2016

Prospective:Whether the trial was registered before participant recruitment began No

Assessment Rationale:How INSPECT-AI determined the prospective registration status by comparing dates Comparison performed at month level. Registration: 2016-05, LLM Recruitment Start: 2016-03. Deemed retrospective at month level.

Study Design EvidenceDates and timelines extracted by INSPECT-AI from the publication text

Recruitment Start: 03-2016

Recruitment Start Rationale:INSPECT-AI's reasoning for how it identified the recruitment start date The study was performed between March 2016 and June 2016. Using start of conducted range as recruitment_start per rule 5; no specific FPI elsewhere.

Recruitment End: N/A

Recruitment End Rationale:INSPECT-AI's reasoning for how it identified the recruitment end date No explicit end-of-recruitment date after full search.

Study End: 06-2016

Study End Rationale:INSPECT-AI's reasoning for how it identified the study end date The study was performed between March 2016 and June 2016. Using end of conducted range as study_end_date per rule 5; no specific completion date.

Overall — What is the overall integrity assessment of the study?

Automated Assessment:Assessment produced by the automated systemN/A
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsSerious concerns

Rationale: Serious concerns in 1.2, 1.3 and 2.1